GeneDx Holdings Corp. Investor Alert: Opportunity to Lead Securities Fraud Lawsuit
A national law firm specializing in shareholder rights has issued an alert regarding a class action lawsuit against GeneDx Holdings Corp. Investors are urged to contact the firm by August 3, 2026, for potential lead plaintiff opportunities.
Silicon Valley, July 31, 2026 – A national shareholder rights litigation firm, Schall Brown & Schwartz LLP, has alerted investors about a class action lawsuit filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS) for alleged violations of federal securities laws.
The lawsuit accuses GeneDx and certain of its officers and directors of making materially false and misleading statements regarding the company's business and financial results. Specifically, the complaint alleges that the company failed to disclose crucial information that negatively impacted its performance and led to a decline in its stock value.
Investors who purchased GeneDx securities during the specified class period and suffered losses are encouraged to contact Schall Brown & Schwartz LLP by August 3, 2026. The firm is seeking individuals who may wish to serve as lead plaintiff in the litigation, a role that involves overseeing the prosecution of the case.
Schall Brown & Schwartz LLP is conducting an investigation into the allegations. GeneDx Holdings Corp. has not yet publicly responded to the lawsuit's claims. Further details regarding the class action and how to participate can be obtained from the law firm.